Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
US6814962B1 · kind B1 · utility
2Cited by
2References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 16, 2000 |
| Grant date | Nov 9, 2004 |
| Priority date | — |
| Expiry date | Nov 16, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant viruses comprising a heterologous DNA sequence coding for a lipase involved in lipoprotein metabolism. The invention also concerns the preparation and use in therapy of said recombinant viruses, especially for the treatment or prevention of dyslipoproteinemia-related pathologies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.